Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins (NCT02346058) | Clinical Trial Compass
CompletedPhase 4
Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins
Taiwan53 participantsStarted 2013-10
Plain-language summary
Evaluation efficacy and safety of Esarin Gel in subjects with chronic venous insufficiency or varicose veins combine superficial vein thrombophlebitis.
Who can participate
Age range20 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
1. Inclusion Criteria:
* Patients of both sexes, aged above 20 years old.
* The patient has confirmed his/her willingness to participate in the study, after being informed about all the aspects of the study that might be relevant for his/her decision to participate, and has signed and dated the informed consent form, as approved by the Institutional Review Board/ Ethics Committee (IRB/EC).
* Presence of chronic venous insufficiency which is rated between functional classes CEAP 0 and 3.(CEAP Classes: C0:no visible or palpable signs of venous disease, C1:telangiectasies or reticular veins. C2 :apparent Varicose veins, C3 :Edema)
* Diagnosed with superficial vein thrombophlebitis and have skin reaction by redness, swelling, fever and pain symptoms.
2. Exclusion Criteria:
* Known allergy to the product's ingredients
* pregnant or breastfeeding
* patient is joining to any other clinical trail
* Patient has not sign the informed consent form
* Deep vein thrombosis
* Cellulitis
* Stasis dermatitis
* The patient is taking non-steroids anti-inflammatory drugs( include oral ,topical creams or patch form)